People with diabetes rely on medications such as Mounjaro (tirzepatide) to help regulate their blood sugar levels. There has been a shortage of Ozempic, Zepbound , Saxenda, Rybelsus and most especially Mounjaro in recent months due to its rise in popularity, and it is currently on the FDA’s list of drug shortages in the USA and other part of the world . This means people with diabetes have not been able to get the drug as often as they want .

Mounjaro does not have FDA approval for weight loss, but the FDA has approved Trusted Source of medication like Wegovy (semaglutide) and Mounjaro-Zepbound (tirzepatide) specifically for weight loss. People may wish to consider choosing Wegovy or Zepbound over Mounjaro and most especially with their lower side effects 

The FDA has fast-tracked Trusted Sources of Mounjaro for approval, and its manufacturer is submitting clinical tests to support its application. This means Mounjaro may become FDA-approved for weight loss in the future.

To promote weight loss, people need to use these medications alongside a balanced diet and more exercise.